Previous 10 | Next 10 |
home / stock / tomdf / tomdf news
Todos Medical ( OTCQB:TOMDF ) said its majority-owned joint venture 3CL Pharma reported results from the first 100-participant study from an Institutional Review Board-waived market research study of Tollovid in long COVID patients. The company said participants ...
New York, NY, and Tel Aviv, ISRAEL, Aug. 19, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical diagnostics and related solutions company, today announced that its majority-owned joint venture 3CL Pharma Ltd. reported the pre...
New York, NY, and Tel Aviv, ISRAEL, Aug. 15, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical diagnostics and related solutions company, today announced that its majority-owned joint venture 3CL Pharma Ltd. reported the pre...
§ 3-arm randomized, controlled study to evaluate 15-day and 30-day treatment regimens § Finalizing contracts with two Long COVID clinics to recruit patients § Institutional Review Board (IRB) protocol submission imminent ...
§ 3-arm randomized, controlled study to evaluate 15-day and 30-day treatment regimens § Finalizing contracts with two Long COVID clinics to recruit patients § Institutional Review Board (IRB) protocol submission imminent New York, NY, and Tel Aviv, I...
New York, NY, and Tel Aviv, ISRAEL , Aug. 10, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical diagnostics and related solutions company, today announced that its CLIA/CAP-certified laboratory Provista Diagnostics has ...
Todos Medical ( OTCQB:TOMDF ) said its laboratory Provista Diagnostics signed two contracts to provide PCR-based monkeypox testing services. Under the first agreement, Provista will provide monkeypox-related testing to a New Jersey-based medical group which specializes in ...
New York, NY, and Tel Aviv, ISRAEL, Aug. 08, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical diagnostics and related solutions company, today announced that its CLIA/CAP-certified laboratory Provista Diagnostics has entere...
RTHM collaborating on Tollovid™ 3CL inhibitor immune support supplement case studies Tollovid biomarker data to support potential structure-function claims in Long COVID New York, NY, and Tel Aviv, ISRAEL, Aug. 05, 2022 (GLOBE NEWSWIRE) -- via NewMed...
FinancialBuzz.com’s latest Buzz on the Street Show: Featuring Our Corporate News Recap on “Todos Medical Initiates Validation Plan for PCR-based MonkeyPox Test at CLIA/CAP Clinical Testing Laboratory Provista Diagnostics.” Todos Medical, Ltd. (OTCQ...
News, Short Squeeze, Breakout and More Instantly...
Signature Bank (SBNY) is expected to report for Q3 2023 BHP Group Ltd. (BHP) is expected to report for Q1 2024 Sorrento Therapeutics Inc. (SRNEQ) is expected to report $-0.15 for Q3 2023 Baran Group Ltd. (BRANF) is expected to report for quarter end 2023-09-30 World Copper (WCUFF)...
NEW YORK, NY, ALPHARETTA, GA and TEL AVIV, Israel, Dec. 22, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire -- Todos Medical, Ltd. (OTCQB: TOMDF) , an innovative healthcare solutions company, today announced that a trustee was appointed (the “Trustee”) with respect to an insol...
GLG Life Tech Corporation (GLGLF) is expected to report for Q1 2024 Accenture plc Class A (Ireland) (ACN) is expected to report $3.14 for Q1 2024 Greenlane Holdings Inc. (GNLN) is expected to report $-2.7 for Q3 2023 iMedia Brands Inc. (IMBIQ) is expected to report for quarter end 202...